End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.54 CNY | -2.63% | -2.57% | -16.22% |
25/04 | Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/04 | Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates | MT |
Business Summary
Number of employees: 3,709
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Flu Vaccine
45.0
%
| 1,818 | 40.2 % | 2,403 | 45.0 % | +32.19% |
Human Serum Albumin
19.8
%
| 988 | 21.9 % | 1,057 | 19.8 % | +6.97% |
Other Blood Products
19.2
%
| 916 | 20.3 % | 1,025 | 19.2 % | +11.87% |
Intravenous C-ball
15.8
%
| 775 | 17.2 % | 845 | 15.8 % | +8.96% |
Other
0.2
%
| 20 | 0.4 % | 13 | 0.2 % | -36.17% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.7
%
| 4,499 | 99.6 % | 5,327 | 99.7 % | +18.40% |
Foreign
0.3
%
| 18 | 0.4 % | 15 | 0.3 % | -17.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bei Fan
CEO | Chief Executive Officer | 52 | 30/92/30 |
Jun Min Xie
DFI | Director of Finance/CFO | 56 | 01/10/01 |
Kang An
CHM | Chairman | 75 | 01/92/01 |
Xiao Wei Ma
CTO | Chief Tech/Sci/R&D Officer | 56 | 12/07/12 |
Wen Jue An
BRD | Director/Board Member | 35 | 01/15/01 |
Yan Chao Wang
BRD | Director/Board Member | 35 | 01/11/01 |
Wen Qi An
BRD | Director/Board Member | 45 | 01/09/01 |
Bao Xian Zhang
BRD | Director/Board Member | 53 | 26/08/26 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 01/93/01 |
Yuan Cheng Lou
IRC | Investor Relations Contact | 40 | 01/08/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kang An
CHM | Chairman | 75 | 01/92/01 |
Bei Fan
CEO | Chief Executive Officer | 52 | 30/92/30 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 01/93/01 |
Xiao Wei Ma
CTO | Chief Tech/Sci/R&D Officer | 56 | 12/07/12 |
Bao Xian Zhang
BRD | Director/Board Member | 53 | 26/08/26 |
Yun Long Wang
BRD | Director/Board Member | 62 | 15/20/15 |
Zhi Guo Su
BRD | Director/Board Member | 70 | - |
Wen Qi An
BRD | Director/Board Member | 45 | 01/09/01 |
Yan Chao Wang
BRD | Director/Board Member | 35 | 01/11/01 |
Wen Jue An
BRD | Director/Board Member | 35 | 01/15/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,828,780,926 | 952,293,137 ( 52.07 %) | 4,414,200 ( 0.2414 %) | 52.07 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.22% | 4.68B | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+55.83% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+3.97% | 8.71B |
- Stock Market
- Equities
- 002007 Stock
- Company Hualan Biological Engineering Inc.